# A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma

> **NCT01718327** · PHASE2 · COMPLETED · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group** · enrollment: 53 (actual)

## Conditions studied

- Unresectable and Advanced Cholangiocarcinoma

## Interventions

- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT01718327
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-01
- **Primary completion:** 2016-11-17
- **Final completion:** 2016-11-17
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718327, "A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01718327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*